Reactions Weekly

, Volume 1695, Issue 1, pp 219–219 | Cite as

Infliximab

Serious infusion reaction: 3 case reports
Case report
  • 16 Downloads

Reference

  1. Papamichael K, et al. Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences 63: 761-767, No. 3, Mar 2018. Available from: URL: http://doi.org/10.1007/s10620-018-4917-7 - USACrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations